Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) EBT Margin (2020 - 2025)

SOPHiA GENETICS's EBT Margin history spans 6 years, with the latest figure at 90.17% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 817.0% to 90.17% in Q4 2025 year-over-year; TTM through Dec 2025 was 100.28%, a 627.0% decrease, with the full-year FY2025 number at 100.28%, down 627.0% from a year prior.
  • EBT Margin hit 90.17% in Q4 2025 for SOPHiA GENETICS, up from 99.57% in the prior quarter.
  • Over the last five years, EBT Margin for SOPH hit a ceiling of 82.01% in Q4 2024 and a floor of 232.52% in Q1 2022.
  • Historically, EBT Margin has averaged 137.89% across 5 years, with a median of 128.68% in 2025.
  • Biggest five-year swings in EBT Margin: tumbled -9334bps in 2022 and later soared 11806bps in 2023.
  • Tracing SOPH's EBT Margin over 5 years: stood at 200.23% in 2021, then surged by 47bps to 106.31% in 2022, then plummeted by -33bps to 141.08% in 2023, then soared by 42bps to 82.01% in 2024, then dropped by -10bps to 90.17% in 2025.
  • Business Quant data shows EBT Margin for SOPH at 90.17% in Q4 2025, 99.57% in Q3 2025, and 118.17% in Q2 2025.